Home Over-the-counter securities and derivatives Page 15

Keyword: Over-the-counter securities and derivatives

163 results found

Stronger over-the-counter disclosure rules take effect

New rule imposes disclosure requirements on issuers that are quoted on the U.S. OTC markets and have a "significant connection" to a Canadian jurisdiction

OTC company and directors broke securities laws, says BCSC panel

News releases falsely stated the value of Brookmount Explorations’ principal mining property

  • By: IE Staff
  • July 4, 2012 July 4, 2012
  • 13:30

CSA proposes mandatory central counterparty clearing of OTC derivatives

Clearing will enhance transparency for regulators and mitigate risks

IOSCO releases final report on standards for OTC derivatives regulation

Report proposes global standards for regulating market participants

Canadian regulators strengthen over-the-counter rules

Canada’s reputation sullied by firms engaged in abusive activities in the U.S. OTC markets

U.S. derivatives reform rife with uncertainty: Fitch

A critical area that is still being debated is the extraterritorial application of the rules

Global regulators committed to OTC derivatives reform

OSC hosts meeting to discuss technical issues relating to implementation efforts

CSA seeks comment on proposed OTC derivatives exemption

The exemption aims to ensure that firms seeking to hedge business risks aren’t discouraged from using OTC derivatives

IOSCO issues recommendations on OTC derivative mandatory clearing

17 recommendations are targeted at authorities developing a mandatory clearing requirement as required by G20

Global policymakers release final report on OTC derivatives data collection

Collecting data centrally would provide regulators and the public with better and more timely information on OTC derivatives